Adma Biologics (ADMA) Enterprise Value (2014 - 2026)
Adma Biologics (ADMA) reported Enterprise Value of $1.75 billion for Q2 2026, down 58.9% from $4.25 billion a year earlier and down 10.5% from the prior quarter.
Powered by 
Analysis
Adma Biologics (ADMA) Enterprise Value (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Adma Biologics' Enterprise Value came in at $1.46 billion, down 63.4% year-over-year; for FY2025, it was $4.25 billion, up 7.5% from FY2024.
- Enterprise Value has increased for five consecutive years, with a five-year compound annual growth rate of 106.9% (FY2020 to FY2025).
- By year, Enterprise Value came in at $3.95 billion in FY2024 (+307.5%), $970.45 million in FY2023 (+25.4%), $774.13 million in FY2022 (+431.3%) and $145.72 million in FY2021 (+30.0%).
- The Q2 2026 figure ranks as the lowest quarterly Enterprise Value since Q1 2024.
- Year over year, Enterprise Value gained in five of the last eight quarters, with growth averaging 123.3%.
- The high point for year-over-year Enterprise Value in five years was Q3 2024 (growth of 531.3%); the low point was Q2 2026 (a decline of 58.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.95 billion (Q1 2026), $4.25 billion (Q4 2025) and $3.43 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Adma Biologics | 2.28 Bn | 1.86 Bn | 86.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.75 Bn |
| Mar 31, 2026 | 1.95 Bn |
| Dec 31, 2025 | 4.25 Bn |
| Sep 30, 2025 | 3.43 Bn |
| Jun 30, 2025 | 4.25 Bn |
| Mar 31, 2025 | 4.66 Bn |
| Dec 31, 2024 | 3.95 Bn |
| Sep 30, 2024 | 4.64 Bn |
| Jun 30, 2024 | 2.52 Bn |
| Mar 31, 2024 | 1.48 Bn |
| Dec 31, 2023 | 970.45 Mn |
| Sep 30, 2023 | 734.77 Mn |
| Jun 30, 2023 | 765.99 Mn |
| Mar 31, 2023 | 666.48 Mn |
| Dec 31, 2022 | 774.13 Mn |
| Sep 30, 2022 | 443.26 Mn |
| Jun 30, 2022 | 336.37 Mn |
| Mar 31, 2022 | 289.81 Mn |
| Dec 31, 2021 | 145.72 Mn |
| Sep 30, 2021 | 121.88 Mn |
API Access
Adma Biologics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=ADMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();